You need to enable JavaScript to run this app.
Recon: Horizon Prices Newly Approved Tepezza at $14,900 per Vial; GSK Pay-for-Delay Appeal Faces EU Rebuke
Recon
Michael Mezher
ReconMichael Mezher
ReconMichael Mezher